CoChat

Combined tissue and fluid proteomics with Tandem Mass Tags to identify low‐abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study

Open access
Russell, Claire L., Heslegrave, Amanda, Mitra, Vikram, Zetterberg, Henrik, Pocock, Jennifer M., Ward, Malcolm A., Pike, Ian · 2017 · Rapid Communications in Mass Spectrometry
Cited by 49

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Rationale: Ideal biomarkers are present in readily accessible samples including plasma and cerebrospinal fluid (CSF), and are directly derived from diseased tissue, therefore likely to be of relatively low abundance. Traditional unbiased proteomic approaches for biomarker discovery have struggled to detect low‐abundance markers due to the high dynamic range of proteins, the predominance of hyper‐abundant proteins, and the use of data‐dependent acquisition mass spectrometry (MS). To overcome these limitations and improve biomarker discovery in peripheral fluids, we have developed TMTcalibrator™; a novel MS workflow combining isobarically labelled diseased tissue digests in parallel with an appropriate set of labelled body fluids to increase the chance of identifying low‐abundance, tissue‐derived biomarkers. Methods: A disease relevant cell line was labelled with TMT® in a range of concentrations generating a multi‐point calibration curve. Peripheral biofluid samples were labelled with the remaining tags and quantitative analysis was performed using an Orbitrap Fusion Tribrid mass spectrometer with a Top10 CID‐HCD MS3 synchronous precursor selection (SPS) method. SPS allowed direct analysis of non‐depleted, unfractionated CSF samples with complete profiling of six individual samples requiring only 15 hours of MS time, equivalent to 1.5 h per sample. Results: Using the TMTcalibrator™ workflow allowed the identification of several markers of microglia activation that are differentially quantified in the CSF of patients with Alzheimer's disease (AD). We report peptides from 41 proteins that have not previously been detected in the CSF, that appear to be regulated by at least 60% in AD. Conclusions: This study has demonstrated the benefits of the new TMTcalibrator™ workflow and the results suggest this is a suitable and efficient method of detecting low‐abundance peptides within biological fluids. The use of TMTcalibrator™ in further biomarker discovery studies should be considered to overcome some of the limitations commonly associated with more conventional approaches. Copyright © 2016 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/rcm.7777

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 49

Metadata

Authors
Russell, C. L., Heslegrave, A., Mitra, V., Zetterberg, H., Pocock, J. M., Ward, M. A., & Pike, I.
Venue
Rapid Communications in Mass Spectrometry
Publisher
Wiley
Published
2016-12-07
Volume
31
Issue
2
Pages
153-159
ISSN
  • 0951-4198 (ISSN-L)
  • 1097-0231
OpenAlex
W2547816148
Cited by
49
References
4
FWCI
1.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combined tissue and fluid proteomics with Tandem Mass Tags to identify low‐abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study. https://app.cochat.ai/papers/10.1002/rcm.7777
The paper
Russell, C. L., Heslegrave, A., Mitra, V., Zetterberg, H., Pocock, J. M., Ward, M. A., & Pike, I. (2017). Combined tissue and fluid proteomics with Tandem Mass Tags to identify low‐abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.7777

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.